AI-powered explanations for X-rays, CT scans, and MRI scans in plain language
Personalized precision medicine powered by AI for cancer therapy
Stage
Not given
Not given
Founded
Not given
Not given
Based in
GB
US
Pricing model
Freemium
Contact for pricing
Pricing
Free: First analysis included with no credit card required. Personal plan: $29 for one complete CT or MRI examination with multiple image series. Pro plan: $69 for 3 image-series analyses. Credits never expire and are one-time purchases with no subscription or automatic renewal.
Not given
Key features
Upload X-ray, CT, and MRI scans in DICOM and image formats
AI-generated plain-language explanations usually within minutes
Unlimited follow-up questions on each analysis
Support for English and Chinese reports and questions
AI visualization viewer for scan analysis
Encrypted storage of medical data in transit and at rest
Automatic deletion of free user scans after 30 days
Cross-referenced insights from multiple scan types and lab results
Analyzes digital pathology with no additional tissue staining required
Rapid results within 1-2 days after specimen receipt
Validated across diverse populations including African American and non-African American men
FDA De Novo authorization for prostate cancer risk stratification
Insurance coverage for Medicare and many commercial plans
Provides 5 and 10-year distant metastasis risk for breast cancer
Identifies breast cancer patients who benefit from chemotherapy
Included in NCCN Clinical Practice Guidelines for Prostate Cancer
What makes it different
Built on Google's MedGemma 1.5 and OpenAI's GPT for medical accuracy
No subscription required; credits never expire
First analysis completely free with no credit card needed
Strong privacy protections with user control over data deletion
Transparent about AI limitations and not positioning as medical diagnosis
No additional tissue preparation needed, uses existing H&E slides
Validated across multiple large randomized phase III clinical trials
FDA De Novo clearance as Software as a Medical Device
Financial assistance program to make tests affordable regardless of income